Automated detection of moderate and large pneumothorax on frontal chest X-rays using deep convolutional neural networks: A retrospective study
- PMID: 30457991
- PMCID: PMC6245672
- DOI: 10.1371/journal.pmed.1002697
Automated detection of moderate and large pneumothorax on frontal chest X-rays using deep convolutional neural networks: A retrospective study
Abstract
Background: Pneumothorax can precipitate a life-threatening emergency due to lung collapse and respiratory or circulatory distress. Pneumothorax is typically detected on chest X-ray; however, treatment is reliant on timely review of radiographs. Since current imaging volumes may result in long worklists of radiographs awaiting review, an automated method of prioritizing X-rays with pneumothorax may reduce time to treatment. Our objective was to create a large human-annotated dataset of chest X-rays containing pneumothorax and to train deep convolutional networks to screen for potentially emergent moderate or large pneumothorax at the time of image acquisition.
Methods and findings: In all, 13,292 frontal chest X-rays (3,107 with pneumothorax) were visually annotated by radiologists. This dataset was used to train and evaluate multiple network architectures. Images showing large- or moderate-sized pneumothorax were considered positive, and those with trace or no pneumothorax were considered negative. Images showing small pneumothorax were excluded from training. Using an internal validation set (n = 1,993), we selected the 2 top-performing models; these models were then evaluated on a held-out internal test set based on area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and positive predictive value (PPV). The final internal test was performed initially on a subset with small pneumothorax excluded (as in training; n = 1,701), then on the full test set (n = 1,990), with small pneumothorax included as positive. External evaluation was performed using the National Institutes of Health (NIH) ChestX-ray14 set, a public dataset labeled for chest pathology based on text reports. All images labeled with pneumothorax were considered positive, because the NIH set does not classify pneumothorax by size. In internal testing, our "high sensitivity model" produced a sensitivity of 0.84 (95% CI 0.78-0.90), specificity of 0.90 (95% CI 0.89-0.92), and AUC of 0.94 for the test subset with small pneumothorax excluded. Our "high specificity model" showed sensitivity of 0.80 (95% CI 0.72-0.86), specificity of 0.97 (95% CI 0.96-0.98), and AUC of 0.96 for this set. PPVs were 0.45 (95% CI 0.39-0.51) and 0.71 (95% CI 0.63-0.77), respectively. Internal testing on the full set showed expected decreased performance (sensitivity 0.55, specificity 0.90, and AUC 0.82 for high sensitivity model and sensitivity 0.45, specificity 0.97, and AUC 0.86 for high specificity model). External testing using the NIH dataset showed some further performance decline (sensitivity 0.28-0.49, specificity 0.85-0.97, and AUC 0.75 for both). Due to labeling differences between internal and external datasets, these findings represent a preliminary step towards external validation.
Conclusions: We trained automated classifiers to detect moderate and large pneumothorax in frontal chest X-rays at high levels of performance on held-out test data. These models may provide a high specificity screening solution to detect moderate or large pneumothorax on images collected when human review might be delayed, such as overnight. They are not intended for unsupervised diagnosis of all pneumothoraces, as many small pneumothoraces (and some larger ones) are not detected by the algorithm. Implementation studies are warranted to develop appropriate, effective clinician alerts for the potentially critical finding of pneumothorax, and to assess their impact on reducing time to treatment.
Conflict of interest statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: AT and JM report research support from GE Healthcare for this project. GE Healthcare has the option to license technologies created from this work for incorporation into commercial products. JM also reports research support (unrelated to this project) from Enlitic, Inc. He is also a participant in the Powerscribe Innovators Program with Nuance, Inc. AT and JM have a potential royalty interest in commercial products derived from this work. The authors do not hold stock in GE (other than in the form of broad-based mutual funds) and do not have any other direct or competing interest in the company.
Figures
References
-
- Chen KY, Jerng JS, Liao WY, Ding LW, Kuo LC, Wang JY et al. Pneumothorax in the ICU: patient outcomes and prognostic factors. Chest. 2002;122(2):678–83. - PubMed
-
- Light R. Pleural diseases 3rd edition Baltimore: Williams & Wilkins; 1995.
-
- Ziegler DW, Agarwal NN. The morbidity and mortality of rib fractures. J Trauma. 1994;37(6):975–9. - PubMed
-
- Hsu CW, Sun SF. Iatrogenic pneumothorax related to mechanical ventilation. World J Crit Care Med. 2014;3(1):8–14. 10.5492/wjccm.v3.i1.8 - DOI - PMC - PubMed
-
- Gupta D, Hansell A, Nichols T, Duong T, Ayres JG, Strachan D. Epidemiology of pneumothorax in England. Thorax. 2000;55:666–71. 10.1136/thorax.55.8.666 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
